Novartis has acquired AveXis
AveXis has provided us with a community update, stating that the company remains steadfastly dedicated to the SMA community. They are excited about the promise of the future as a part of this organisation and hope to accelerate their mission of bringing AVXS‐101 to people with SMA as quickly and safely as possible.